Omeros Historical Balance Sheet

OMER Stock

USD 10.54 0.84 7.38%

Trend analysis of Omeros balance sheet accounts such as Other Current Liab of 17.7 M provides information on Omeros' total assets, liabilities, and equity, which is the actual value of Omeros to its prevalent stockholders. By breaking down trends over time using Omeros balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Omeros latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Omeros is a good buy for the upcoming year.

Omeros Inventory

9.37 Million

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.

About Omeros Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Omeros at a specified time, usually calculated after every quarter, six months, or one year. Omeros Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Omeros and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Omeros currently owns. An asset can also be divided into two categories, current and non-current.

Omeros Balance Sheet Chart

At this time, Omeros' Other Assets are relatively stable compared to the past year. As of 12/11/2024, Cash And Short Term Investments is likely to grow to about 180.4 M, while Other Current Liabilities is likely to drop slightly above 17.7 M.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Omeros assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Omeros books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Most accounts from Omeros' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Omeros current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Omeros. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

To learn how to invest in Omeros Stock, please use our How to Invest in Omeros guide.At this time, Omeros' Other Assets are relatively stable compared to the past year. As of 12/11/2024, Cash And Short Term Investments is likely to grow to about 180.4 M, while Other Current Liabilities is likely to drop slightly above 17.7 M.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	347.8M	342.0M	361.6M	379.7M
Total Assets	419.3M	591.0M	378.3M	397.2M

Short Long Term Debt Total Total Assets

Omeros balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt
Common Stock Shares Outstanding		0.75	0.81	0.81	0.72	-0.08	0.76	-0.59	0.63	-0.48	0.72	0.43	0.65	0.41	0.62	0.78	0.54	0.99	0.69	0.59	0.43	0.46	0.65	0.74	0.76	0.42
Total Assets	0.75		0.93	0.52	0.85	0.06	0.75	-0.4	0.9	-0.52	0.6	0.48	0.94	0.77	0.93	0.95	0.74	0.69	0.86	0.85	0.6	0.74	0.91	0.78	0.98	0.72
Short Long Term Debt Total	0.81	0.93		0.65	0.7	-0.03	0.84	-0.48	0.9	-0.53	0.63	0.48	0.93	0.74	0.92	0.97	0.49	0.78	0.87	0.84	0.76	0.65	0.88	0.88	0.88	0.47
Other Current Liab	0.81	0.52	0.65		0.59	-0.25	0.79	-0.51	0.41	-0.33	0.53	0.25	0.44	0.25	0.37	0.58	0.33	0.81	0.53	0.44	0.39	0.07	0.49	0.77	0.54	0.18
Total Current Liabilities	0.72	0.85	0.7	0.59		0.03	0.65	-0.33	0.65	-0.35	0.41	0.23	0.65	0.58	0.61	0.73	0.92	0.66	0.71	0.6	0.24	0.44	0.71	0.62	0.91	0.9
Total Stockholder Equity	-0.08	0.06	-0.03	-0.25	0.03		-0.47	0.07	0.33	0.68	0.18	0.08	0.08	0.15	0.12	-0.05	0.15	-0.13	-0.08	-0.32	-0.01	0.29	-0.27	-0.43	0.05	0.13
Property Plant And Equipment Net	0.76	0.75	0.84	0.79	0.65	-0.47		-0.44	0.54	-0.67	0.55	0.5	0.72	0.42	0.67	0.79	0.44	0.73	0.66	0.79	0.51	0.29	0.81	0.99	0.72	0.35
Current Deferred Revenue	-0.59	-0.4	-0.48	-0.51	-0.33	0.07	-0.44		-0.38	0.27	-0.47	-0.18	-0.36	-0.26	-0.34	-0.43	-0.24	-0.56	-0.41	-0.38	-0.31	-0.25	-0.39	-0.44	-0.4	-0.15
Net Debt	0.63	0.9	0.9	0.41	0.65	0.33	0.54	-0.38		-0.33	0.56	0.35	0.93	0.88	0.94	0.88	0.5	0.61	0.83	0.72	0.79	0.82	0.76	0.63	0.84	0.54
Retained Earnings	-0.48	-0.52	-0.53	-0.33	-0.35	0.68	-0.67	0.27	-0.33		-0.28	-0.24	-0.54	-0.4	-0.52	-0.57	-0.21	-0.51	-0.53	-0.73	-0.43	-0.49	-0.7	-0.68	-0.48	-0.23
Accounts Payable	0.72	0.6	0.63	0.53	0.41	0.18	0.55	-0.47	0.56	-0.28		0.79	0.65	0.19	0.62	0.57	0.35	0.66	0.31	0.45	0.31	0.53	0.47	0.54	0.53	0.14
Cash	0.43	0.48	0.48	0.25	0.23	0.08	0.5	-0.18	0.35	-0.24	0.79		0.56	-0.05	0.54	0.43	0.3	0.35	0.07	0.43	0.08	0.39	0.42	0.46	0.4	0.07
Non Current Assets Total	0.65	0.94	0.93	0.44	0.65	0.08	0.72	-0.36	0.93	-0.54	0.65	0.56		0.79	0.99	0.91	0.51	0.62	0.77	0.86	0.74	0.79	0.88	0.79	0.85	0.51
Non Currrent Assets Other	0.41	0.77	0.74	0.25	0.58	0.15	0.42	-0.26	0.88	-0.4	0.19	-0.05	0.79		0.81	0.76	0.4	0.42	0.86	0.69	0.82	0.72	0.72	0.53	0.72	0.57
Other Assets	0.62	0.93	0.92	0.37	0.61	0.12	0.67	-0.34	0.94	-0.52	0.62	0.54	0.99	0.81		0.9	0.48	0.59	0.78	0.85	0.76	0.82	0.86	0.74	0.84	0.5
Cash And Short Term Investments	0.78	0.95	0.97	0.58	0.73	-0.05	0.79	-0.43	0.88	-0.57	0.57	0.43	0.91	0.76	0.9		0.56	0.75	0.93	0.86	0.73	0.68	0.9	0.83	0.93	0.56
Net Receivables	0.54	0.74	0.49	0.33	0.92	0.15	0.44	-0.24	0.5	-0.21	0.35	0.3	0.51	0.4	0.48	0.56		0.44	0.49	0.47	-0.05	0.43	0.58	0.38	0.82	0.94
Common Stock Total Equity	0.99	0.69	0.78	0.81	0.66	-0.13	0.73	-0.56	0.61	-0.51	0.66	0.35	0.62	0.42	0.59	0.75	0.44		0.68	0.58	0.47	0.46	0.62	0.73	0.7	0.35
Short Term Investments	0.69	0.86	0.87	0.53	0.71	-0.08	0.66	-0.41	0.83	-0.53	0.31	0.07	0.77	0.86	0.78	0.93	0.49	0.68		0.78	0.78	0.59	0.82	0.73	0.86	0.59
Non Current Liabilities Total	0.59	0.85	0.84	0.44	0.6	-0.32	0.79	-0.38	0.72	-0.73	0.45	0.43	0.86	0.69	0.85	0.86	0.47	0.58	0.78		0.64	0.62	0.99	0.83	0.8	0.5
Other Current Assets	0.43	0.6	0.76	0.39	0.24	-0.01	0.51	-0.31	0.79	-0.43	0.31	0.08	0.74	0.82	0.76	0.73	-0.05	0.47	0.78	0.64		0.57	0.62	0.63	0.49	0.07
Other Stockholder Equity	0.46	0.74	0.65	0.07	0.44	0.29	0.29	-0.25	0.82	-0.49	0.53	0.39	0.79	0.72	0.82	0.68	0.43	0.46	0.59	0.62	0.57		0.64	0.36	0.66	0.46
Total Liab	0.65	0.91	0.88	0.49	0.71	-0.27	0.81	-0.39	0.76	-0.7	0.47	0.42	0.88	0.72	0.86	0.9	0.58	0.62	0.82	0.99	0.62	0.64		0.85	0.87	0.6
Property Plant And Equipment Gross	0.74	0.78	0.88	0.77	0.62	-0.43	0.99	-0.44	0.63	-0.68	0.54	0.46	0.79	0.53	0.74	0.83	0.38	0.73	0.73	0.83	0.63	0.36	0.85		0.73	0.33
Total Current Assets	0.76	0.98	0.88	0.54	0.91	0.05	0.72	-0.4	0.84	-0.48	0.53	0.4	0.85	0.72	0.84	0.93	0.82	0.7	0.86	0.8	0.49	0.66	0.87	0.73		0.8
Short Term Debt	0.42	0.72	0.47	0.18	0.9	0.13	0.35	-0.15	0.54	-0.23	0.14	0.07	0.51	0.57	0.5	0.56	0.94	0.35	0.59	0.5	0.07	0.46	0.6	0.33	0.8

Click cells to compare fundamentals

Omeros Account Relationship Matchups

Omeros balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	49.5M	57.2M	62.3M	62.7M	62.7M	38.8M
Total Assets	137.0M	181.0M	419.3M	591.0M	378.3M	397.2M
Short Long Term Debt Total	161.7M	240.1M	347.8M	342.0M	361.6M	379.7M
Other Current Liab	46.6M	28.8M	27.5M	25.7M	31.9M	17.7M
Total Current Liabilities	55.5M	36.7M	51.8M	136.7M	53.3M	35.4M
Total Stockholder Equity	(734.6M)	(872.7M)	23.8M	85.7M	(25.0M)	(26.2M)
Property Plant And Equipment Net	30.9M	28.1M	30.0M	23.3M	20.6M	21.6M
Net Debt	32.7M	22.1M	247.0M	331.0M	354.5M	372.2M
Retained Earnings	(734.6M)	(872.7M)	(683.1M)	(635.7M)	(753.5M)	(715.9M)
Accounts Payable	5.3M	4.2M	13.4M	6.0M	7.7M	5.1M
Cash	3.1M	10.5M	100.8M	11.0M	7.1M	11.3M
Non Current Assets Total	33.2M	29.8M	171.4M	147.7M	160.4M	168.4M
Non Currrent Assets Other	1.2M	625K	67K	124.5M	139.8M	146.8M
Other Assets	2.3M	27.2M	141.4M	124.5M	143.2M	150.3M
Cash And Short Term Investments	60.8M	135.0M	157.3M	194.9M	171.8M	180.4M
Net Receivables	35.2M	3.8M	82.5M	242.0M	6.7M	6.4M
Common Stock Total Equity	542K	616K	626K	628K	722.2K	404.0K
Short Term Investments	57.7M	124.5M	56.5M	183.9M	164.7M	173.0M
Liabilities And Stockholders Equity	(488.6M)	(570.9M)	419.3M	591.0M	378.3M	397.2M
Non Current Liabilities Total	190.5M	265.1M	343.7M	368.6M	349.9M	367.4M
Other Current Assets	6.6M	11.1M	8.1M	6.3M	39.3M	41.3M
Other Stockholder Equity	(542K)	(616K)	706.3M	720.8M	727.9M	764.3M
Total Liab	246.0M	301.8M	395.5M	505.3M	403.3M	423.4M
Property Plant And Equipment Gross	30.9M	28.1M	30.0M	23.3M	26.7M	28.1M
Total Current Assets	103.7M	151.3M	247.9M	443.2M	217.9M	228.8M
Short Term Debt	3.5M	3.8M	10.5M	99.8M	13.7M	12.0M
Common Stock	542K	616K	626K	721.4M	611K	580.5K
Property Plant Equipment	3.8M	28.1M	30.0M	23.3M	26.7M	28.1M
Long Term Debt	158.2M	236.3M	313.5M	220.9M	254.0M	266.7M
Net Tangible Assets	(76.7M)	(92.0M)	52.9M	233.2M	268.2M	281.6M
Retained Earnings Total Equity	(734.6M)	(872.7M)	(683.1M)	(635.7M)	(572.1M)	(600.8M)
Long Term Debt Total	158.2M	236.3M	313.5M	220.9M	254.0M	159.7M
Capital Surpluse	625.0M	751.3M	706.3M	720.8M	828.9M	593.0M
Inventory	52.5M	48.3M	114.5M	8.6M	9.9M	9.4M
Other Liab	8.7M	8.2M	1.1M	444K	399.6K	379.6K
Capital Lease Obligations	35.8M	32.6M	34.4M	26.7M	30.7M	20.9M

Pair Trading with Omeros

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Omeros position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Omeros will appreciate offsetting losses from the drop in the long position's value.

Moving together with Omeros Stock

0.85	ESPR	Esperion Therapeutics	Pair Corr
0.74	BMY	Bristol Myers Squibb	Pair Corr

Moving against Omeros Stock

0.85	AMGN	Amgen Inc	Pair Corr
0.75	PFE	Pfizer Inc Fiscal Year End 4th of February 2025	Pair Corr
0.73	AVDL	Avadel Pharmaceuticals	Pair Corr
0.69	JNJ	Johnson Johnson Fiscal Year End 28th of January 2025	Pair Corr
0.64	TTOO	T2 Biosystms	Pair Corr

The ability to find closely correlated positions to Omeros could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Omeros when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Omeros - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Omeros to buy it.

The correlation of Omeros is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Omeros moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Omeros moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Omeros can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Omeros Stock Analysis

When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Omeros Historical Balance Sheet

Omeros Inventory

9.37 Million

About Omeros Balance Sheet Analysis

Omeros Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Omeros balance sheet Correlations

Omeros Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Omeros balance sheet Accounts

Pair Trading with Omeros

Moving together with Omeros Stock

Moving against Omeros Stock

Additional Tools for Omeros Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Property Plant And Equipment Gross	+ 0.99	Property Plant And Equipment Net
Other Assets	+ 0.99	Non Current Assets Total
Total Liab	+ 0.99	Non Current Liabilities Total
Total Current Assets	+ 0.98	Total Assets
Cash And Short Term Investments	+ 0.97	Short Long Term Debt Total

Non Current Liabilities Total	- 0.73	Retained Earnings
Total Liab	- 0.7	Retained Earnings
Property Plant And Equipment Gross	- 0.68	Retained Earnings
Retained Earnings	- 0.67	Property Plant And Equipment Net
Current Deferred Revenue	- 0.59	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.57	Retained Earnings